Skip to main content
. 2021 Mar 30;22(7):3608. doi: 10.3390/ijms22073608

Table 5.

Studies on A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTSs) in PrCa.

Authors Year ADAMTS PrCa Platform Role
Binder et al. [221] 2020 ADAMTS-15 Yes—Prostate samples, prostate cell lines and mice ADAMTS-15 expressed and active in PrCa samples. Enforced ADAMTS-15 expression decreased migration and proliferation but increased survival in vitro and suppressed tumor growth in mice.
Cross et al. [222] 2005 ADAMTS-1, 4, 5, 9 and 15 Yes—Prostate cell lines ADAMTS-1, ADAMTS-4, ADAMTS-5, ADAMTS-9 and ADAMTS-15 expressed in PrCa.
Gustavsson et al. [185] 2008 ADAMTS-1 * Yes—Prostate cell lines and mice ADAMTS-1 expression decreased in PrCa cell line with enhanced angiogenic and tumorigenic properties, compared to parent.
Gustavsson et al. [220] 2009 ADAMTS-1 Yes—Prostate samples ADAMTS-1 expression decreased in prostate cancer cells compared to benign prostate glands. No correlation with Gleason score, but expression lower in patients with metastatic disease.
Gustavsson et al. [219] 2010 ADAMTS-1 Yes—Prostate cell lines and mice ADAMTS-1 ablation decreased tumor growth, but in other PrCa cells enforced expression inhibited tumor growth.
Jennbacken et al. [65] 2009 ADAMTS-1 Yes—Prostate cell lines and mice ADAMTS-1 expression increased in slow growing tumors in mice.
Kim et al. [179] 2012 ADAMTS-1 * Yes—Prostate samples ADAMTS-1 mRNA overexpressed in PrCa samples.
Molokwu et al. [223] 2010 ADAMTS-1 and 15 Yes—Prostate cell lines ADAMTS-15 (but not ADAMTS-1) expressed in PrCa.

* Included in at least one other table.